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1. Introduction 
Neonatal pneumonia is a serious respiratory infectious disease caused by a variety of 
microorganisms, mainly bacteria, with the potential of high mortality and morbidity (1,2). 
Worldwide neonatal pneumonia is estimated to account for up to 10% of childhood 
mortality, with the highest case fatality rates reported in developing countries (3,4). It´s 
impact may be increased in the case of early onset, prematurity or an underlying pulmonary 
condition like RDS, meconium aspiration or CLD/bronchopulmonary dysplasia (BPD), 
when the pulmonary capacity is already limited. Ureaplasma pneumonia and ventilator-
associated pneumonia (VAP) have also been associated with the development of BPD and 
poor pulmonary outcome (5,6,7). In this chapter we will review different aspects of neonatal 
pneumonia and will present case reports from our level III neonatal unit in Graz. 
2. Epidemiology 
Reported frequencies of neonatal pneumonia range from 1 to 35 %, the most commonly 
quoted figures being 1 percent for term infants and 10 percent for preterm infants (8). The 
incidence varies according to gestational age, intubation status, diagnostic criteria or case 
definition, the level and standard of neonatal care, race and socioeconomic status. In a 
retrospective analysis of a cohort of almost 6000 neonates admitted to our NICU pneumonia 
was diagnosed in all gestational age classes. The incidence of bacterial pneumonia including 
Ureaplasma urealyticum (Uu) pneumonia was 1,4 % with a median patient gestational age 
of 35 weeks (range 23-42 weeks) and a mortality of 2,5%. There was only one case of viral 
pneumonia, due to RSV-infection and no case of fungal pneumonia. The mortality rate 
associated with pneumonia is in general inversely related to gestational age and 
birthweight, being higher in cases of early onset compared to late onset, and especially high 
in low socioecomomic groups and developing countries (2,3,4). Group B Streptococcus 
accounts for most cases of early onset pneumonia, the commonest bacteria causing late-
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onset pneumonia are gram-negative bacilli such as E coli or Klebsiella spp.(8). Frequently 
bacterial pathogens found in early and late onset sepsis/pneumonia are listed in Table 1.  
3. Pathogenesis 
Pneumonia may be acquired by intrauterine (e.g. transplacental hematogenous, ascending 
from birth canal), intrapartum (e.g aspiration) or postnatal routes (e.g. hematogenous, 
environmental). The pathogens include mainly bacteria, followed by viruses and fungi 
which induce an inflammatory pulmonary condition (1,8). This may cause epithelial injury 
to the airways, leakage of proteinaceous fluid into the alveoli and interstitium, leading to 
surfactant deficiency or dysfunction. Data from a German study (9) suggest that respiratory 
insufficiency in pneumonia is most likely caused by inhibition of surface-tension-lowering 
properties of surfactant rather than by surfactant deficiency. Important predisposing factors 
in the evolution of pneumonia are immaturity, low birth weight, premature rupture of 
membranes, chorioamnionitis and factors associated with prolonged neonatal intensive care 
(2, 8).  
4. Clinical presentation, classification  
Depending on the time of manifestation of infection neonatal pneumonia may be classified 
as early onset pneumonia (within the first 3 or 7 days of life, mostly within 48 hours), or late 
onset pneumonia (within 4 and 28 days of life). Congenital or intrauterine pneumonia can 
be considered a variant of early onset pneumonia (2). Other classifications refer to the 
underlying pathogen, like bacterial or viral pneumonia or the pattern of lung infiltrates (e.g. 
interstitial pneumonia) on chest radiographs. Clinical signs are unspecific and present as 
respiratory distress of various degree, suspicious appearing tracheal aspirates, cough, 
apnea, high or low temperature, poor feeding, abdominal distension, and lethargy. 
Tachypnea is a predominant clinical sign, present in 60-89 % of cases (2). Persistent fever is 
rather unusual, but has been reported in neonates with viral pneumonia (10). The 
radiographical appearance may also vary (11), showing reticulogranular-nodular infiltrates, 
and bilateral streaky or hazy lungs. As small bronchioli tend to collapse there may be 
compensatory hyperaeration in areas free of pneumonial infiltration. In addition there may 
be pleural effusions and/or pneumatocele formation in more complicated cases. Alveolar 
patterns with coarse, patchy parenchymal infiltrates, consolidation, and diffuse granularity 
are more typical for bacterial infections while parahilar streakiness, diffuse hazy lungs or 
reticulo-nodularity are more common in viral disease. The differential diagnoses to be 
considered on initial presentation are mainly surfactant deficiency syndrome and transient 
tachypnoe of the newborn, in addition meconium aspiration syndrome (MAS), pulmonary 
hemorrhage, pulmonary edema, primary pulmonary lymphangiectasis or pulmonary 
lymphangiomatosis, congestive heart failure (11,12) and Wilson-Mikity-syndrome (13). 
Additional investigations like echocardiography, high-resolution computed tomography, 
further laboratory studies, and in rare cases lung biopsy are helpful in the diagnostic work 
up.  
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5. Diagnosis 
The clinical diagnosis of pneumonia is challenging and may not always be correct (over- or 
underestimated). Early tracheal aspirate cultures obtained within the first 8 to 12 hours of age 
may help in diagnosing congenital pneumonia (14,15), especially in certain clinical conditions, 
including maternal fever, clinical chorioamnionitis and leukopenia. But even a positive blood 
culture or proven airway colonization do not necessarily correlate with the clinical picture of 
sepsis or pneumonia (16). In the clinical routine pneumonia is diagnosed based on a 
combination of perinatal risk factors, signs of neonatal respiratory distress, positive laboratory 
studies, radiological signs and a typical clinical course. Some clinical scenarios are more or less 
suspicious . For example VAP, reported to be responsible for up to one third of all nosocomial 
infections, may be suspected two or more days after the initiation of mechanical ventilation 
when new or persistent infiltrates are noticed in 2 or more chest radiographs (5). Additional 
definition criteria developed by the Centers for disease control and prevention (17) include an 
increase in oxygen and ventilator requirements and at least three of the following signs and 
symptoms: temperature instability, wheezing, tachypnea, cough, abnormal heart rate, change 
in respiratory secretions, and abnormal peripheral white blood count. The most common 
organisms in VAP in extremely preterm infants have been shown to be Staphylococcus aureus 
and especially gram-negative organisms like Pseudomonas aeruginosa , Enterobacter spp. and 
Klebsiella spp. (18). Pneumonia caused by Ureaplasma species, Eubacteria mainly colonizing 
the mucosal surface of the respiratory and urogenital tract, may be diagnosed by direct 
isolation of the organism from endotracheal aspirates using culture or PCR-techniques, by 
typical chest-x-ray patterns showing disseminated, patchy infiltrates bilaterally with 
progression to cystic dysplasia, and elevated inflammatory serum-parameters like CRP or an 
increased white cell count (19,20,21). An organism frequently associated with early onset 
pneumonia is Group B Streptococcus. The clinical manifestation occurs usually within 6 of 8 
hours of life and can initially mimic surfactant deficiency syndrome (16, 22). 
6. Treatment, prevention 
As pneumonia is often associated with or non distinguishable from bacterial sepsis initial 
therapy at the NICU includes broad spectrum intravenous antibiotics according to local 
protocols. In our unit we start with a combination of ampicillin and a second generation 
cephalosporine. Although there is no evidence from randomized controlled trials that any 
antibiotic regime is superior for suspected early onset neonatal sepsis (23), the WHO 
recommends as first line treatment ampicillin plus gentamycin (24). In cases where we 
detect pathogens in blood, or in endotracheal aspirates we treat according to susceptibility 
from antibiogram results. A problem which is increasing worldwide in NICU´s is the 
occurrence of multidrug resistant pathogens, mainly gram-negative bacilli (25). As an 
alternative to systemic treatment aerosolized antibiotics like colistin have been used 
successfully in patients with VAP caused by multidrug resistant gram negative bacteria (26, 
27). In patients where we suspect or diagnose an U infection we initiate treatment with 
intravenous clarithromycin (10mg/kg/day), a macrolid antibiotic. In a recently published 
randomized controlled placebo single-center study clarithromycin treatment resulted in 
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eradication of Uu in 68,5 % of the patients and a significantly lower incidence of BPD (2.9% 
vs. 36.4%) in preterm infants weighing between 750 to 1250 g (28). Azithromycin, another 
macrolid antibiotic, which has good inhibitory activity against Ureaplasma in in-vitro 
studies, may also be beneficial for BPD prevention in Ureaplasma colonized/infected 
preterm infants, especially when used early and for longer duration (29). In general the 
clinical and microbiological effectiveness of macrolid antibiotics, the most commonly used 
in the literature being erythromycin, has not yet been shown in adequately powered 
randomized controlled clinical trials (30). Recommendations for the duration of antibiotic 
therapy in proven neonatal pneumonia range from 10 to 21 days (8). Surfactant therapy may 
be beneficial in selected patients by mechanisms improving lung function and decreasing 
bacterial growth, but may require repeated doses (22, 31,32). However, in a recently 
published meta- analysis in patients > 35 weeks gestation with proven or suspected 
pneumonia with onset during the first 28 days of life there was no evidence of a significant 
effect on the primary outcome death, time to resolution of pneumonia, BPD, pneumothorax 
and pulmonary hemorrhage (33). There are still open questions related to the surfactant 
preparation, dosage, optimal treatment frequency, number of doses and patient selection. 
Severe cases of pneumonia with respiratory insufficiency not responding to conventional 
therapy may occasionally be candidates for ECMO (34, 35). Preventative measures to be 
considered include maternal infection control in the prenatal period, prenatal screening and 
prophylaxis for streptococcal colonization (36), preference of non-or minimal invasive 
procedures in the neonatal period like respiratory support without intubation (37), 
immunoprophylaxis against RSV-infection, and general infection control measures in the 
neonatal unit to reduce the incidence and transmission of health-care-associated infections, 
the most important being hand hygiene (38,39,40). Preventive strategies that may have a 
great impact are maternal and infant vaccination programs, as has been already shown in 
developing countries e.g for pneumococcal polysaccharide vaccines (41). 
 
Early onset (< =7 days) Late onset (> 7 days)
Group B Streptococcus (g +) Escherichia coli (g-) 
Escherichea coli (g-) Staphylococcus epidermidis (g+) 
Staphylococcus aureus (g+) Klebsiella-Enterobacter-species (g-) 
Listeria monocytogenes (g+) Pseudomonas aeruginosa (g-) 
Enterococcus (g +)  
Ureaplasma urealyticum (g+)*  
g +/- = gram-positive/negative 
* based on DNA-analysis 
Table 1. Frequently found bacterial organisms in early and late onset neonatal sepsis and pneumonia 
Case 1 
A male neonate was born at 42 weeks gestational age to a multiparous healthy mother 
following spontaneous labor in an external hospital. The membranes ruptured 3 hours 
before delivery. There was no prenatal maternal screening for groub B streptococci disease. 
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After good primary transition, the infant developed clinical signs of respiratory distress 
with oxygen dependency and respiratory acidosis (6 hours post partum). After initiation of 
our standard broad spectrum antibiotic therapy the infant was transferred to our NICU. A 
septic workup showed leukopenia of 2.70 G/L, a left shift in the white cell count 
(immature/total neutrophils (I/T) 0,33), markedly elevated procalcitonin (303 ng/mL) and 
interleukin-6 (IL-6 > 400 pg/L) levels, but normal CRP values, and a positive urinary group B 
streptococcus testing. Blood cultures and tracheal aspirates were negative. Radiographics 
showed bilateral reticulogranular patterns compatible with the diagnosis of RDS (Figure 1). 
The patient was first placed on nasal CPAP but had to be intubated and ventilated 
mechanically due to respiratory deterioration with an increasing oxygen demand up to an 
FiO2 of 1,0 and persistent respiratory acidosis. Surfactant therapy showed no sufficient 
response. Inotropic support was necessary in case of arterial hypotension. Following inhaled 
nitric oxide therapy a decrease in oxygen requirement from 100 to 50 % was achieved over 
the following 48 hours, indicative of secondary pulmonary hypertension. On day 5 of life 
the clinical course was complicated by formation of a large left sided pneumatocele (Figure 
2) and a consecutive symptomatic tension pneumothorax (Figure 3), which was successfully 
treated by insertion of a chest drain. On day 11 of life the patient was extubated, but the 
chest drain had to be left in situ for 3 ½ weeks due to recurrent air leaks. Laboratory 
parameters normalized within a week by our standard antibiotic regime. On day 37 of life 
the neonate had recovered and was discharged home.  
 
 
 
Figure 1. Bilateral reticulogranular lung pattern in Group B Streptococcus pneumonia mimicking RDS 
(Case 1) 
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Figure 2. Pneumatocele formation on the leftside and streaky-granular infiltrates in Group B 
Streptococcus pneumonia (Case 1) 
 
Figure 3. Leftsided tension pneumothorax complicating Group B Streptococcus pneumonia (Case 1) 
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Case 2 
A female infant was delivered by vacuum extraction at 37+4 weeks gestational age to a 
multiparous mother after premature rupture of membranes, meconium stained amniotic 
fluid and pathological cardiotocogram. Maternal vaginal swabs were tested negative for 
Group B Streptococcus. Apgar scores and umbilical artery pH were within the normal 
range. About 12 hours after birth the neonate showed signs of respiratory distress with 
tachypnea, grunting and an oxygen demand of FiO2 >0,3. He was intubated and transferred 
to our NICU. A chest radiograph on admission showed bilateral streaky infiltrates (Figure 
4). On day 2 an elevated CRP of 100mg/L, in combination with the findings on chest 
radiographs and the clinical signs were highly suspicious for the diagnosis of early onset 
neonatal pneumonia. In the yellowish tracheal aspirates Listeria monocytogenes were 
detected. The asymptomatic mother was tested negative for Listeria infection in stool and 
u r i n e  p r o b e s .  O n  c l o s e r  q u e s t i o n i n g  t h e  m o t h e r  r e m e m b e r e d  h a v i n g  
 
 
 
 
 
 
 
Figure 4. Bilateral,streaky and nodular infiltrates in Listeria pneumonia (Case 2) 
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developed gastrointestinal symptoms with diarrhea 2 weeks prior to birth after having eaten 
some cheese made from unpasteurized milk from a local food store. This led us to assume 
that the pregnant mother had most likely infected the fetus following ingestion of the 
bacterium, which had then crossed intestinal cells into the bloodstream and passed the 
placenta (42,43). After initiation of our standard antibiotic therapy the infant recovered 
quickly and was extubated on day 4 of life. Antibiotics were given for a total of 14 days. The 
child had a full recovery. 
Case 3 
A female infant was born to a primigravid mother at 28+1 weeks of gestational age. Delivery 
was by cesarean section due to a pathological cardiotocogram and presumed maternal 
infection (preterm premature rupture of the membranes 9 hours before delivery, preterm 
labour, increased neutrophile count and elevated CRP). The mother was treated with  
 
 
 
 
 
 
 
 
Figure 5. Bilateral lung infiltrates with consolidation mainly in the middle and right lower lobe in 
Enterobacter pneumonia (Case 3) 
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antibiotics. The preterm infant showed clinical and radiological signs of RDS and was 
intubated 15 minutes after birth. Standard broad spectrum antibiotics were started 
prophylactically but terminated after 3 days when daily white cell counts and CRP levels 
revealed no signs of infection. The patient was extubated on day 4 of life and placed on 
nasal CPAP. On day 6 of life the baby appeared septic with new onset of apneas, skin pallor, 
poor peripheral perfusion, metabolic acidosis and neurological signs like increased muscle 
tone and extreme irritability. Due to recurrent apneas despite caffeine therapy the infant had 
to be reintubated. The septic work up confirmed the clinical diagnosis of sepsis. 
Enterobacter cloacae, ESBL positive, was found in the blood culture, liquor cerebrospinalis 
and tracheal aspirate. Peripheral blood count showed leukocytosis, I/T ratio of 0,54, 
thrombocytopenia of 38 G/l, and elevated CRP values of 68,4 rising to a maximum of > 200 
mg/L. Chest radiographs revealed new parenchymal changes compatible with the diagnosis 
of late onset bacterial pneumonia (Figure 5). The antibiotic regime was changed to 
meropenem and teicoplanin. As a further complication of sepsis the patient developed 
transient renal failure and an intraventricular hemorrhage with consecutive hydrocephalus, 
which was finally treated by insertion of a ventriculo-peritoneal shunt. After a long 
complicated neonatal period the patient was finally discharged from the hospital at an age 
of about 3 months in good clinical condition. 
Case 4 
A female infant was born at 24+3 weeks gestational age by vaginal delivery after the 
mother had been admitted to our hospital 1 hour prior to delivery with abdominal pain 
and onset of labors. The neonate developed RDS soon after birth which led to intubation, 
surfactant application and mechanical ventilation. Broad spectrum antibiotic therapy was 
started in case of suspected early onset sepsis. Initial laboratory revealed leukocytosis of 
52.00 G/L, increased IL-6 (29,2 pg/ml) but normal CRP values. The chest radiograph on 
admission was typical for mild RDS but the lung pattern worsened during the first 2 
weeks of life showing disseminated streaky-patchy infiltrates and partly cystic changes 
(Figure 6 and 7), accompanied by an increase in ventilatory requirements suggestive of 
early BPD changes. Therefore a strategy of moderate early BPD-prevention (48) with a one 
week course of intravenous steroids (hydrocortisone) was started. Results from routine 
tracheal aspirate screening for Ureaplasma infection taken during the second day on 
mechanical ventilation revealed a positive culture test (106) for Uu. In addition the 
placenta histology showed signs of chorioamnionitis. Under the assumption of early onset 
ureaplasma pneumonia/ pneumonitis we commenced oral macrolid therapy with 
clarithromycin (10mg/kg), beginning on day 6 of life for a total of 14 days. A repeat 
ureaplasma culture taken during treatment was negative. Mechanical ventilation 
continued for 18 days followed by a prolonged period of NCPAP lasting 7 weeks. Oxygen 
dependency for more than 8 weeks but not at a corrected gestational age of 36 weeks was 
compatible with the diagnosis of mild BPD (44,45). At an age of about 4 months of life she 
was discharged home. 
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Figure 6. Streaky-patchy lung changes with partly cystic appearance in Ureaplasma urealyticum 
pneumonia on day 6 of life (Case 4) 
 
 
 
Figure 7. Early BPD changes in Ureaplasma urealyticum pneumonia on day 18 of life (Case 4) 
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7. Conclusion 
Despite advances in neonatal medicine pneumonia remains a serious problem even in 
developed countries, mainly due to the increased survival of very preterm births and their 
susceptibility for early and late bacterial infections. The clinical spectrum of pneumonia is 
complex, symptoms are often non-specific and laboratory findings may be of limited value, 
making a rapid and correct diagnosis difficult. Treatment may also be challenging if no 
organism can be cultivated or in case of multidrug-resistant bacterial pneumonia. There is 
no clear evidence from randomized controlled trials favoring a specific antibiotic treatment 
strategy so that treatment decisions are based on local antimicrobial resistance patterns and 
clinical experience. Surfactant substitution might be beneficial in selected cases. Preventive 
strategies like health-care associated infection control and vaccination programs might have 
the greatest impact and should be further evaluated and applied at all levels of perinatal 
care. 
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